Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 38 months, Aug 2023 to Sep 2026.
Portfolio value
₹432 Cr
up ₹82.6 Cr vs Jul 2024
- Stocks held
- 17
- down 1 vs Jul 2024
- Top 10 weight
- 66.2%
- of the portfolio in its ten largest
- Cash & debt
- 7.0%
- cash, money market and debt
- Moves this month
- 1 in · 2 out
- added to 10, trimmed 2
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In August 2024 it disclosed 17 stocks worth ₹432 Cr, up ₹82.6 Cr from Jul 2024. Its largest positions were HFCL Limited (8.3%), Pfizer Limited (8.1%), Aurobindo Pharma Limited (7.9%); the ten largest together made up 66.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 73.3% of its equity. Cash and debt stood at 7.0%. Compared with Jul 2024 the fund entered 1 new stock and exited 2.
Against 229 other Sectoral / Thematic funds
Concentration
91%
Top-10 weight is higher than 91% of peers
Breadth
4%
Holds more stocks than 4% of peers
Cash
85%
Holds more cash than 85% of peers
What these mean: concentration · cash
Holdings in August 2024
Download CSVEvery line the fund disclosed, with the change against Jul 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| HFCL Limited | 8.29% | up 8.29 pts | ₹35.8 Cr | up ₹35.8 Cr | New |
| Pfizer Limited | 8.06% | down 1.23 pts | ₹34.8 Cr | up ₹2.4 Cr | Added |
| Aurobindo Pharma Limited | 7.90% | down 1.03 pts | ₹34.1 Cr | up ₹2.9 Cr | Added |
| Dr. Reddy's Laboratories Limited | 7.19% | down 1.35 pts | ₹31 Cr | up ₹1.2 Cr | Added |
| Cash, TREPS & receivables | 6.97% | up 2.97 pts | ₹30.1 Cr | up ₹16.1 Cr | Added |
| Zydus Wellness Limited | 6.83% | up 0.41 pts | ₹29.5 Cr | up ₹7.1 Cr | Added |
| GlaxoSmithKline Pharmaceuticals Limited | 6.43% | down 1.48 pts | ₹27.7 Cr | up ₹15 L | Added |
| Aster DM Healthcare Limited | 5.75% | up 1.42 pts | ₹24.8 Cr | up ₹9.7 Cr | Added |
| IPCA Laboratories Limited | 5.49% | up 4.55 pts | ₹23.7 Cr | up ₹20.4 Cr | Added |
| SMS Pharmaceuticals Limited | 5.20% | down 0.57 pts | ₹22.4 Cr | up ₹2.3 Cr | Added |
| Zydus Lifesciences Limited | 5.10% | down 1.87 pts | ₹22 Cr | down ₹2.3 Cr | Trimmed |
| Divi's Laboratories Limited 26/09/2024 Derivative | 4.76% | up 4.76 pts | ₹20.5 Cr | up ₹20.5 Cr | New |
| Glenmark Life Sciences Limited | 4.51% | up 3.11 pts | ₹19.5 Cr | up ₹14.6 Cr | Added |
| Aarti Pharmalabs Limited | 4.48% | down 0.61 pts | ₹19.3 Cr | up ₹1.6 Cr | Added |
| Sequent Scientific Limited | 4.32% | up 0.35 pts | ₹18.6 Cr | up ₹4.8 Cr | Added |
| Divi's Laboratories Limited | 3.41% | up 0.31 pts | ₹14.7 Cr | up ₹3.9 Cr | Added |
| Suven Life Sciences Limited | 2.74% | down 0.68 pts | ₹11.8 Cr | down ₹9 L | Trimmed |
| RPG Life Sciences Limited | 1.88% | down 0.29 pts | ₹8.1 Cr | up ₹56 L | Added |
| Sanofi Consumer Healthcare India Limited | 0.69% | down 0.16 pts | ₹3 Cr | — | Held |
What changed, Jul 2024 to Aug 2024
New New positions (1)
- HFCL Limited8.3% · ₹35.8 Cr
Exited Exited (2)
- Poly Medicure Limitedwas 8.0% · ₹27.9 Cr
- Alembic Pharmaceuticals Limitedwas 1.9% · ₹6.5 Cr
Added Biggest additions
- IPCA Laboratories Limitedup ₹20.4 Cr (+4.55% pts)
- Glenmark Life Sciences Limitedup ₹14.6 Cr (+3.11% pts)
- Aster DM Healthcare Limited ₹9.7 Cr (+1.42% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2024, the weight rose most in Telecom - Services (+9.4 pts) and Healthcare Services (+0.9 pts), and fell most in Healthcare Equipment & Supplies (−9.0 pts) and Pharmaceuticals & Biotechnology (−1.8 pts).
- Telecom - Services0.0% → 9.4%new+9.4 pts
- Healthcare Services8.7% → 9.6%+0.9 pts
- Food Products7.2% → 7.7%+0.5 pts
- Healthcare Equipment & Supplies9.0% → 0.0%exited−9.0 pts
- Pharmaceuticals & Biotechnology75.1% → 73.3%−1.8 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2023 | Feb 2024 | May 2024 | Jul 2024 | Aug 2024 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 50.2% | 43.1% | 65.0% | 75.1% | 73.3% |
| Healthcare Services | 19.7% | 15.1% | 16.1% | 8.7% | 9.6% |
| Telecom - Services | — | — | — | — | 9.4% |
| Food Products | — | — | — | 7.2% | 7.7% |
Allocation in Aug 2024change vs Jul 2024
- Pharmaceuticals & Biotechnology (13)73.3%▼ 1.8 pts
- Healthcare Services (2)9.6%▲ 0.9 pts
- Telecom - Services (1)9.4%▲ 9.4 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Aug 2024
7.0%
▲ 1.5 pts vs Jul 2024
- Cash alone
- 7.0%
- cash and net receivables
- A year earlier
- 3.1%
- Aug 2023 · now ▲ 3.9 pts
- Last 12 months
- 0.5% – 7.5%
- lowest to highest · record 7.5% in Feb 2024
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.